image credit: Freepik

Recro to Expand its Clinical Trial Services Offerings

Recro Pharma, a contract development and manufacturing organization (CDMO), announced on June 2, 2021 that it has expanded the clinical capabilities of its clinical trial services (CTS) offerings.

The added capabilities include clinical-scale sachet and blister packaging for clinical trial pharmaceuticals and a relationship with a European Union Qualified Person (QP) for its CTS offerings, the company said in a press release. Based on an audit completed by the QP, Recro meets the relevant GMP manufacturing standards and requirements for clinical trial materials to be used in the European Union.

Read More on Biopharm International